More studies show how COVID-19 aftermath survival may be driven by heart conditions across all demographics. InfoBionic explains why remote cardiac monitoring will be foundational to improving patient outcomes in an evolving long term.

As concerns grow over the long-term cardiovascular health implications of COVID-19, health providers look to remote patient monitoring and telehealth to improve patient outcomes. Leading ambulatory cardiac monitoring provider InfoBionic sees a tremendous challenge ahead where thousands will deal with long-term cardiovascular health effects of COVID-19. “Although we’re still learning about COVID-19, it’s transformed our healthcare system’s monitoring and treatment approaches for patients,” InfoBionic CEO Stuart Long said. With cardiovascular injury a long-term effect for COVID-19 survivors, healthcare needs a proven means of telemetry style remote cardiac monitoring that can facilitate faster interventions that can improve health outcomes.”

Studies have shown that up to 20 percent of patients with COVID-19 may have heart injury due to coronavirus, which researchers attribute to inflammation from infection.(1) This comes at a time when a small but increasing number of cases in the US and elsewhere show that otherwise healthy people with coronavirus are suffering blood vessel injuries, blood clots, arrhythmia, strokes, and heart attacks due to excessive clotting.(2)

COVID-19 Causes, Hotspots and the Heart

A growing understanding among researchers and cardiologists is that the coronavirus appears to enter and infect the heart cells though ACE2 receptors. These receptors are prevalent in the lungs, the heart and blood vessels where the virus can lead to cell dysfunction and cellular death.(3) Current inflammation drugs used to treat the infection can also exacerbate underlying heart issues.(4)

While the most recent data shows that 20 states are classified as hotspots (i.e. increasing infection rates), healthcare must simultaneously deal with the long-term health implications of COVID-19 survivors.(5) There is a growing prevalence of reports showing the lasting heart impairments of the coronavirus and how persistent inflammation can cause chronic cardiac complications after recovery.(6)(7)

There is a new understanding of the cardiovascular dangers for young as well as older patients with and without comorbidities. These long-term health risks positions remote patient monitoring (RPM) to impact everything from sick leave and disability policies to research studies on the long-term effects of a COVID-19 aftermath.(8)

The understanding of COVID-19 and the long-term health effects of survivors and what they might need in terms of healthcare is still being studied.(9) but it’s already clear that a significant portion of the more than 2.5 million Americans who’ve contracted coronavirus may have lingering symptoms. This can be seen in the mounting stories of those who have survived COVID-19 but face ongoing health challenges, with many being heart-related conditions.(10)

Heart Monitoring and Long-term COVID Heart Health

COVID-19 complications connected to heart health may emerge and disappear. Healthcare providers will need ways to monitor the cardiovascular health of these patients remotely to curb hospital readmissions and circumvent heart issues before they become serious according to Long.

Remote cardiac monitoring and telehealth are obvious solutions to this problem as telehealth and RPM use for recovering COVID-19 patients becomes more prevalent.(11) The new reality of RPM and telehealth can be seen in the following surveys:

  • 88 percent of healthcare providers have invested in, or are evaluating, RPM technologies.(12)
  • A survey of HR executives showed that 77 percent of respondents saw telehealth as a permanent change regardless of the length of the pandemic.(13)

The reality is that monitoring a significant post-COVID-19 patient population in the long term will be a reality that requires health providers, cardiologists, and hospitals to have solutions that are simple and unobtrusive for the patient. According to Long, the implications of RPM are far reaching beyond the countless conditions associated with inflammation impacting heart health. “A major need for effective RPM will include studies impacting longer health outcomes and treatments of these conditions,” Long explained. Physicians and cardiologists will need non-invasive cardiac monitors that provide full disclosure data to deal effectively with these needs without disrupting patient lives.”

The evolution of these monitoring interventions and studies will require healthcare providers and researchers to continuously review user experience, adoption rates and resulting outcomes. This will impact future interventions, treatments  and understanding of how viruses generally and COVID-19 specifically impact the body long-term. The recent update of legislation from the Food and Drug Administration allowing usage modifications in the function of RPM tools during the COVID-19 Outbreak will go a long way to changing the dynamic of long-term health outcomes.(14)

About InfoBionic: 

InfoBionic is a digital health company transforming the efficiency and economics of ambulatory remote patient monitoring processes by optimizing clinical and real-world utility for the users that need it most—physicians and their patients. The Massachusetts-based team of seasoned entrepreneurs leverages successful careers in healthcare, IT, medical devices, and mobile technology, along with specific expertise in remote monitoring and cardiology. Their first-hand experience with the complexities of traditional cardiac arrhythmia detection and monitoring processes led to design of the transformative MoMe® Kardia platform to remove the roadblocks, thus amounting to a faster and more effective process for decision-making and diagnosis. InfoBionic is the recipient of the Frost & Sullivan 2019 North American Remote Cardiac Monitoring Technology Leadership Award. For more information, visit

1. Shi S, Qin M, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China, JAMA Cardiology, March 25, 2020,
2. Katherine Harmon Courage. “Coronavirus’s new mystery: It’s causing strokes in healthy people,” Vox, May 1, 2020,
3. Julia Reis. “COVID-19 Can Attack the Heart in Addition to the Lungs,” Healthline, May 20, 2020,
4. Lun Wang, Yang Zhang, Shuyang Zhang. “Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy,” Frontiers in Cardiovascular Medicine, April 30, 2020.
5. Jennifer Kates, et al. “Where are the COVID-19 Hotspots? Tracking State Outbreaks,” Kaiser Family Foundation, June 24, 2020,
6. Brit Long William J. Brady, Alex Koyfman Michael Gottlieb. “Cardiovascular complications in COVID-19,” American Journal of Emergency Medicine, April 14, 2020,
7. Akbarshakh Akhmerov, Eduardo Marbán. COVID-19 and the Heart, AHA Journals circulation research, April 3, 2020,
8. Lisa Du. “Virus Survivors Could Suffer Severe Health Effects for Years,” Blomberg, May 12, 2020,
9. Lois Parshley. The emerging long-term complications of Covid-19, explained,” Voc, June 12, 2020, com/2020/5/8/21251899/coronavirus-long-term-effects-symptoms
10. Rick Jervis, Lindsay Schnell, Alan Gomez, and Deborah Barfield Berry. “Memory loss, gnarled fingers, panic attacks: COVID-19 didn’t kill these Americans, but many might never be the same,” USA Today, June 19, 2020,
11. Kevin Joy. “How Remote Patient Monitoring Is Aiding the COVID-19 Fight,” HealthTech Magazine, June 11, 2020, net/article/2020/06/how-remote-patient-monitoring-aiding-covid-19-fight-perfcon
12. Samantha McGrail. “88% of Providers Investing in Remote Patient Monitoring Tech,” mHealth Intelligence, November 4, 2019,
13. Rafi Musher, Mark Bremer, et al. “Forecasting the long-term impact of telemedicine,” Stax, April 20, 2020,
14. Coronavirus (COVID-19) Update: FDA allows expanded use of devices to monitor patients’ vital signs remotely, FDA, March 20, 2020,